Nouveau Life Pharmaceuticals, Inc.
NOUV
$0.0001
$0.000.00%
| 09/30/2011 | |||||
|---|---|---|---|---|---|
| Revenue | 6.00K | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | 6.00K | ||||
| Cost of Revenue | 5.50K | ||||
| Gross Profit | 600.00 | ||||
| SG&A Expenses | -- | ||||
| Depreciation & Amortization | -- | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | 5.50K | ||||
| Operating Income | 600.00 | ||||
| Income Before Tax | 600.00 | ||||
| Income Tax Expenses | -- | ||||
| Earnings from Continuing Operations | 600.00 | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | 600.00 | ||||
| EBIT | 600.00 | ||||
| EBITDA | -- | ||||
| EPS Basic | 0.00 | ||||
| Normalized Basic EPS | 0.00 | ||||
| EPS Diluted | 0.00 | ||||
| Normalized Diluted EPS | 0.00 | ||||
| Average Basic Shares Outstanding | 152.00M | ||||
| Average Diluted Shares Outstanding | 152.00M | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||
